Late onset tuberculosis infection in patients receiving anti-TNFα therapy

QJM. 2014 Jan;107(1):69-71. doi: 10.1093/qjmed/hct174. Epub 2013 Aug 22.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Psoriatic / drug therapy
  • Female
  • Humans
  • Immunocompromised Host
  • Infliximab
  • Male
  • Middle Aged
  • Opportunistic Infections / chemically induced*
  • Opportunistic Infections / immunology
  • Tuberculosis / chemically induced*
  • Tuberculosis / immunology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab